The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, ...

Eli Lilly & Co.’s fourth-quarter revenue fell short of analysts’ estimates as its popular weight-loss and diabetes shots ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Karyopharm Therapeutics Inc. (KPTI), a company focused on novel cancer therapies, said on Thursday that it has appointed Lori ...

Immunocore (IMCR) has appointed Travis Coy as EVP, CFO and Head of Corporate Development ... He brings over 20 years of experience working at Eli Lilly, where his most recent role was Vice ...

most recently served as CFO of Legend Biotech Corporation. Previously, she held leadership roles of increasing responsibility at Ametek PDS, Cello Health, Eli Lilly and Company, and Pfizer.

CFO Lucas Montarce said of the share buyback ... Adam Spatacco has positions in Eli Lilly. The Motley Fool has positions in and recommends JPMorgan Chase. The Motley Fool has a disclosure policy.

Immunocore Holdings hired a non-executive director on its board as the company's chief financial officer. The U.K. biotechnology company Thursday said Travis Coy has been appointed CFO and head of ...

He had a 14-year career at Eli Lilly, including roles in corporate finance ... as well as working as a regional CFO in Europe. He left Lilly to move back to Canada and began working as a public ...

He had a 14-year career at Eli Lilly, including roles in corporate ... as well as working as a regional CFO in Europe. He left Lilly to move back to Canada and began working as a public company ...

Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human ...